Previous Article | Next Article 
Molecular and Cellular Biology, March 2005, p. 1645-1654, Vol. 25, No. 5
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.5.1645-1654.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Ikaros Induces Quiescence and T-Cell Differentiation in a Leukemia Cell Line
Katie L. Kathrein,
Rachelle Lorenz,
Angela Minniti Innes,
Erin Griffiths, and
Susan Winandy*
Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Received 9 July 2004/
Returned for modification 30 August 2004/
Accepted 30 November 2004
Ikaros is a hematopoietic cell-specific zinc finger DNA binding protein that plays an important role in lymphocyte development. Genetic disruption of Ikaros results in T-cell transformation. Ikaros null mice develop leukemia with 100% penetrance. It has been hypothesized that Ikaros controls gene expression through its association with chromatin remodeling complexes. The development of leukemia in Ikaros null mice suggests that Ikaros has the characteristics of a tumor suppressor gene. In this report, we show that the introduction of Ikaros into an established mouse Ikaros null T leukemia cell line leads to growth arrest at the G0/G1 stage of the cell cycle. This arrest is associated with up-regulation of the cell cycle-dependent kinase inhibitor p27kip1, the induction of expression of T-cell differentiation markers, and a global and specific increase in histone H3 acetylation status. These studies provide strong evidence that Ikaros possesses the properties of a bona fide tumor suppressor gene for the T-cell lineage and offer insight into the mechanism of Ikaros's tumor suppressive activity.
* Corresponding author. Mailing address: Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, 320 E. Superior St., Morton 6-639, Chicago, IL 60611. Phone: (312) 503-3075. Fax: (312) 503-1339. E-mail:
s-winandy{at}northwestern.edu.
Molecular and Cellular Biology, March 2005, p. 1645-1654, Vol. 25, No. 5
0022-538X/05/$08.00+0 doi:10.1128/MCB.25.5.1645-1654.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Trageser, D., Iacobucci, I., Nahar, R., Duy, C., von Levetzow, G., Klemm, L., Park, E., Schuh, W., Gruber, T., Herzog, S., Kim, Y.-m., Hofmann, W.-K., Li, A., Storlazzi, C. T., Jack, H.-M., Groffen, J., Martinelli, G., Heisterkamp, N., Jumaa, H., Muschen, M.
(2009). Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. JEM
206: 1739-1753
[Abstract]
[Full Text]
-
Chari, S., Winandy, S.
(2008). Ikaros Regulates Notch Target Gene Expression in Developing Thymocytes. J. Immunol.
181: 6265-6274
[Abstract]
[Full Text]
-
Kathrein, K. L., Chari, S., Winandy, S.
(2008). Ikaros Directly Represses the Notch Target Gene Hes1 in a Leukemia T Cell Line: IMPLICATIONS FOR CD4 REGULATION. J. Biol. Chem.
283: 10476-10484
[Abstract]
[Full Text]
-
Ma, S., Pathak, S., Trinh, L., Lu, R.
(2008). Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development. Blood
111: 1396-1403
[Abstract]
[Full Text]
-
Thomas, R. M., Chunder, N., Chen, C., Umetsu, S. E., Winandy, S., Wells, A. D.
(2007). Ikaros Enforces the Costimulatory Requirement for IL2 Gene Expression and Is Required for Anergy Induction in CD4+ T Lymphocytes. J. Immunol.
179: 7305-7315
[Abstract]
[Full Text]
-
Dumortier, A., Jeannet, R., Kirstetter, P., Kleinmann, E., Sellars, M., dos Santos, N. R., Thibault, C., Barths, J., Ghysdael, J., Punt, J. A., Kastner, P., Chan, S.
(2006). Notch Activation Is an Early and Critical Event during T-Cell Leukemogenesis in Ikaros-Deficient Mice. Mol. Cell. Biol.
26: 209-220
[Abstract]
[Full Text]